🔥🐔 BizChicken 🐔🔥
Companies Similar to Cognition Therapeutics, Inc.
Sign Up Today!
Sign up for BizChicken and discover more about the corporations around you.
Alector, Inc.
AL001, AL101, AL002, AL003, AL044
Alector, Inc. is a clinical stage biopharmaceutical company focused on developing therapies for neurodegeneration diseases. The company has several products in various stages of clinical trials aimed at treating conditions such as Alzheimer's, Parkinson's, and frontotemporal dementia.
About | Vision/Values | History | Leadership | Contact | Culture | Vision/Values | History | About | About | About | About | Careers | About | About
Symbol: ALEC
Recent Price: $1.72
Industry: Biotechnology
CEO: Dr. Arnon Rosenthal Ph.D.
Sector: Healthcare
Employees: 245
Address: 131 Oyster Point Boulevard, South San Francisco, CA 94080
Phone: 415 231 5660
Leadership
- Arnon Rosenthal, Ph.D., Co-Founder, Chief Executive Officer, and Director
- Sara Kenkare-Mitra, Ph.D., President and Head of Research and Development
- Marc Grasso, M.D., Chief Financial Officer
- Gary Romano, M.D., Ph.D., Chief Medical Officer
- Danielle Pasqualone, Ph.D., J.D., General Counsel
- Clare Hunt, M.B.A., Chief People Officer
- Kristina Cutter, M.P.H., Chief Regulatory, Pharmacovigilance, and Quality Assurance Officer
- Virginia DeJesus-Rueff, M.B.A., Chief of Staff and Head of Strategy
- Norah Conway, Senior Vice President, Portfolio and Program Management
- Neil Berkley, M.S., M.B.A., Chief Business Officer
- Louis J. Lavigne Jr., M.B.A., Chairperson of the Board
- Elizabeth Garofalo, M.D., Board Member
- Paula Hammond, Ph.D., Board Member
- Richard H. Scheller, Ph.D., Board Member
- David Wehner, Board Member
- Kristine Yaffe, M.D., Board Member
- Errol De Souza, Ph.D., Board Member
- Mark Altmeyer, M.B.A., Board Member
Last updated: 2024-12-31
Athira Pharma, Inc.
ATH-1017
Athira Pharma, Inc. is a late clinical-stage biopharmaceutical company focused on developing small molecules to restore neuronal health and slow neurodegeneration, with its lead product, ATH-1017, in clinical trials for Alzheimer's and Parkinson's diseases.
Symbol: ATHA
Recent Price: $0.55
Industry: Biotechnology
CEO: Dr. Mark J. Litton M.B.A., Ph.D.
Sector: Healthcare
Employees: 65
Address: 18706 North Creek Parkway, Bothell, WA 98011
Phone: 425 620 8501
Last updated: 2024-12-31
Contineum Therapeutics, Inc. Class A Common Stock
PIPE-791
Contineum Therapeutics, Inc. is a clinical stage biopharmaceutical company focused on discovering and developing novel oral small molecule therapies for neuroscience, inflammation, and immunology indications with high unmet need.
Symbol: CTNM
Recent Price: $14.47
Industry: Biotechnology
CEO: Mr. Carmine N. Stengone MBA, MS
Sector: Healthcare
Employees: 31
Address: 10578 Science Center Drive, San Diego, CA 92121
Phone: (858) 333-5280
Leadership
- Carmine Stengone, President and Chief Executive Officer
- Austin Chen, PhD, Senior Vice President, Head of Research
- Beverly Dixon, Senior Director, Quality Assurance
- Kristina Haeckl, Sr. Vice President, Regulatory Affairs
- Daniel Lorrain, PhD, Chief Scientific Officer
- John Healy, General Counsel & Corporate Secretary
- Jon Seiders, PhD, Vice President, CMC
- Jules Lee, Senior Director, Clinical Operations
- Julie Iwashita, Vice President, Clinical Operations
- Karin Stebbins, Vice President, Toxicology
- Michael Mayberry, Vice President, Finance
- Mike Poon, PhD, Vice President, Biology
- Peter Slover, Chief Financial Officer
- Stephen Huhn, MD, Chief Medical Officer & Senior Vice President, Clinical Development
- Tara Vargas, Senior Director, Project Management
- Thomas O. Schrader, PhD, Senior Director, Chemistry
- Varsha Dourado, Vice President, Business Development
Last updated: 2024-12-31
Cyclerion Therapeutics, Inc.
CY6463
Cyclerion Therapeutics is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing medicines for serious CNS diseases, with products like CY6463 for mitochondrial encephalomyopathy and Alzheimer's disease.
Symbol: CYCN
Recent Price: $3.45
Industry: Biotechnology
CEO: Dr. Regina Graul Ph.D.
Sector: Healthcare
Employees: 1
Address: 245 First Street, Cambridge, MA 02142
Phone: 857 327 8778
Last updated: 2024-12-31
Pasithea Therapeutics Corp.
Therapies for CNS diseases
Pasithea Therapeutics Corp. is a biotechnology company engaged in research and discovery of treatments for psychiatric and neurological disorders. It plans to operate anti-depression clinics and provide business support services, using trained pharmacists to administer intravenous infusions of ketamine. Founded in 2020, the company is based in Miami Beach, Florida.
Symbol: KTTA
Recent Price: $2.95
Industry: Biotechnology
CEO: Dr. Tiago Reis Marques M.D., Ph.D.
Sector: Healthcare
Employees: 8
Address: 1111 Lincoln Road, Miami Beach, FL 33139
Phone: 702 514 4174
Last updated: 2024-12-31
Tonix Pharmaceuticals Holding Corp.
TNX-1500, TNX-2900, TNX-801, TNX-1840, TNX-1850, TNX-3500
Tonix Pharmaceuticals Holding Corp. is a clinical-stage biopharmaceutical company that focuses on developing therapies for immunology, rare diseases, infectious diseases, and central nervous system disorders. Key products include TNX-1500 for organ transplant and autoimmune diseases, TNX-2900 for Prader-Willi syndrome, and TNX-801 for smallpox prevention.
Symbol: TNXP
Recent Price: $0.36
Industry: Biotechnology
CEO: Dr. Seth Lederman M.D.
Sector: Healthcare
Employees: 103
Address: 26 Main Street, Chatham, NJ 07928
Phone: 862 799 8599
Last updated: 2024-12-31
Alto Neuroscience, Inc.
ALTO-100, ALTO-300, ALTO-101, ALTO-203, ALTO-202
Alto Neuroscience, Inc. is a clinical-stage biopharmaceutical company specializing in psychiatry drug development, with a range of innovative treatments targeting major depressive disorder and cognitive impairments.
Symbol: ANRO
Recent Price: $4.20
Industry: Biotechnology
CEO: Dr. Amit Etkin M.D., Ph.D.
Sector: Healthcare
Employees: 78
Address: 369 South San Antonio Road, Los Altos, CA 94022
Phone: (650) 200-0412
Last updated: 2024-12-31
Alzamend Neuro, Inc.
AL001 and AL002
Alzamend Neuro, Inc., an early clinical-stage biopharmaceutical company, focuses on developing products for neurodegenerative and psychiatric disorders. Their pipeline includes AL001 for Alzheimer's and psychiatric disorders, and AL002 for Alzheimer's disease using a novel vaccine approach.
About | About | Contact | Contact | Contact | Contact | Careers | About | About | About | About | About
Symbol: ALZN
Recent Price: $1.20
Industry: Biotechnology
CEO: Mr. Stephan Jackman
Sector: Healthcare
Employees: 4
Address: 3500 Lenox Road NE, Atlanta, GA 30326
Phone: 844 722 6333
Last updated: 2024-12-31
Axsome Therapeutics, Inc.
AXS-05, AXS-07, AXS-12, AXS-14
Axsome Therapeutics, Inc. is a biopharmaceutical company focused on developing novel therapies for central nervous system disorders such as major depressive disorder, migraine, narcolepsy, and fibromyalgia.
About | Leadership | Directors | About | About | About | About | About | About | Contact | Careers | Careers | About | About
Symbol: AXSM
Recent Price: $84.78
Industry: Biotechnology
CEO: Dr. Herriot Tabuteau M.D.
Sector: Healthcare
Employees: 589
Address: 22 Cortlandt Street, New York, NY 10007
Phone: 212 332 3241
Leadership
- Herriot Tabuteau, MD, CHIEF EXECUTIVE OFFICER
- Nick Pizzie, CPA, MBA, CHIEF FINANCIAL OFFICER
- Mark Jacobson, MA, CHIEF OPERATING OFFICER
- Hunter Murdock, Esq., GENERAL COUNSEL
- ari Maizel, Executive Vice President, Head of Commercial
- Mark Coleman, MD, DIRECTOR
- Roger Jeffs, PhD, DIRECTOR
- Susan Mahony, PhD, MBA, DIRECTOR
- Mark Saad, DIRECTOR
Last updated: 2024-12-31
C4 Therapeutics, Inc.
CFT7455
C4 Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel therapeutic candidates to degrade disease-causing proteins for the treatment of cancer, neurodegenerative conditions, and other diseases. Their lead product candidate, CFT7455, targets multiple myeloma and non-Hodgkin lymphomas.
Symbol: CCCC
Recent Price: $3.64
Industry: Biotechnology
CEO: Mr. Andrew J. Hirsch M.B.A.
Sector: Healthcare
Employees: 145
Address: 490 Arsenal Way, Watertown, MA 02472
Phone: 617 231 0700
Leadership
- Kendra Adams, Chief Financial Officer
- Scott Boyle, Ph.D., Chief Business Officer
- Stew Fisher, Ph.D., Chief Scientific Officer
- Len Reyno, M.D., Chief Medical Officer
- Jolie Siegel, Chief Legal Officer
- Kelly Schick, Chief People Officer
- Mary Christian, Pharm. D., Senior Vice President, Regulatory
- Mayra Reyes-Armour, Ph.D., Senior Vice President, Technical Operations, Quality and Facilities
- Ron Cooper, Chairman
- Ken Anderson, M.D., Director
- Laura Bessen, M.D., Director
- Bruce Downey, Director
- Stephen Fawell, Ph.D., Director
- Donna Grogan, M.D., Director
- Andrew Hirsch, President and Chief Executive Officer, Director
- Owen Hughes, Director
- Utpal Koppikar, Director
- Marc Cohen, In MemoriamCo-Founder & Executive Chairman Emeritus
Last updated: 2024-12-31
Cognition Therapeutics, Inc.
CT1812
Cognition Therapeutics is a clinical-stage biopharmaceutical company specializing in small molecule therapeutics for age-related degenerative diseases and central nervous system disorders. Its lead product, CT1812, is designed to treat Alzheimer's disease and dementia with Lewy bodies.
Symbol: CGTX
Recent Price: $0.75
Industry: Biotechnology
CEO: Ms. Lisa Ricciardi
Sector: Healthcare
Employees: 25
Address: 2500 Westchester Avenue, Purchase, NY 10577
Phone: 412 481 2210
Leadership
- Lisa Ricciardi, Chief Executive Officer
- Anthony C. Caggiano, M.D., Ph.D., Chief Medical Officer, Head of R&D
- John Doyle, Chief Financial Officer
- Anita Cornet, Head of Quality
- Theresa Devins, DrPH, Vice President, Clinical Operations
- Mary Hamby, Ph.D., Vice President, Research
- Bobby Horn, Corporate Controller
- Jennifer Iaci, Vice President, Development Operations
- Steven A. Weissman, Ph.D., Vice President and Head of CMC
- Jack A. Khattar, CEO
- Aaron Fletcher, Ph.D.,
- Brett P. Monia, Ph.D., CEO
- Ellen B. Richstone,
- Peggy Wallace,
Last updated: 2024-12-31
Cingulate Inc.
CTx-1301
Cingulate Inc. is focused on developing product candidates for treating attention-deficit/hyperactivity disorder (ADHD) and anxiety disorders. Its pipeline includes CTx-1301 and CTx-1302 for ADHD, and CTx-2103 for anxiety.
About | Management | Directors | About | About | Contact | Contact | Careers | About | About | About
Symbol: CING
Recent Price: $4.98
Industry: Biotechnology
CEO: Dr. Shane J. Schaffer Pharm.D.
Sector: Healthcare
Employees: 13
Address: 1901 West 47th Place, Kansas City, KS 66205
Phone: 913 942 2300
Leadership
- Shane J. Schaffer, PharmD, Chairman, Chief Executive Officer
- Peter J. Werth, Director
- Jeff Ervin, Director
- Bryan Lawrence, Director
- Jay Roberts, Director
Last updated: 2024-12-31
Compass Therapeutics, Inc.
CTX-009, CTX-471, CTX-8371
Compass Therapeutics, Inc. is a clinical-stage oncology-focused biopharmaceutical company developing antibody-based therapeutics to treat various human diseases. Their clinical stage products include investigational bispecific antibodies like CTX-009 and monoclonal antibodies such as CTX-471.
Symbol: CMPX
Recent Price: $1.48
Industry: Biotechnology
CEO: Dr. Thomas J. Schuetz M.D., Ph.D.
Sector: Healthcare
Employees: 32
Address: 80 Guest Street, Boston, MA 02135
Phone: 617 500 8099
Last updated: 2024-12-31
Cogent Biosciences, Inc.
CGT9486
Cogent Biosciences, Inc. is a biotechnology company focused on developing precision therapies for genetically defined diseases, with lead product candidate CGT9486 targeting mutations driving systemic mastocytosis and advanced gastrointestinal stromal tumors.
Symbol: COGT
Recent Price: $7.67
Industry: Biotechnology
CEO: Mr. Andrew R. Robbins M.B.A.
Sector: Healthcare
Employees: 164
Address: 200 Cambridge Park Drive, Cambridge, MA 02140
Phone: 617 945 5576
Last updated: 2024-12-31
Cyclo Therapeutics, Inc.
Trappsol Cyclo
Cyclo Therapeutics, Inc. is a clinical stage biotechnology company focused on developing cyclodextrin-based products for various diseases, with its lead drug candidate Trappsol Cyclo undergoing Phase III trials for Niemann-Pick Type C disease and exploration for Alzheimer's treatment.
Contact | Contact | News | About | About | About | About | About | About | About | About | About | Careers | About | About | About
Symbol: CYTH
Recent Price: $0.60
Industry: Drug Manufacturers - Specialty & Generic
CEO: Mr. N. Scott Fine
Sector: Healthcare
Employees: 8
Address: 6714 NW 16th Street, Gainesville, FL 32653
Phone: 386 418 8060
Last updated: 2024-12-31
Intensity Therapeutics, Inc.
INT230-6
Intensity Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of cancer drugs for treating solid tumors. Their lead product, INT230-6, is undergoing Phase 2 trials for various cancers and is being tested in collaborations with major pharmaceutical companies.
Symbol: INTS
Recent Price: $1.82
Industry: Biotechnology
CEO: Mr. Lewis H. Bender M.A., M.B.A., M.S.
Sector: Healthcare
Employees: 5
Address: 61 Wilton Road, Westport, CT 06880
Phone: 203 221 7381
Leadership
- Lewis H. Bender, M.S., M.A., M.B.A., Founder and CEO
- Joseph Talamo, CPA, Chief Financial Officer
- James M. Ahlers, Executive Vice President
- Brian Schwartz, MD, Executive VP, Clinical Development
- John Wesolowski, CPA, MBA, Principal Accounting Officer and Controller
- Kimberly A. Guedes, RN, MBA, Vice President of Clinical Operations
- Doranne Frano, Regulatory Affairs and Quality Control
- Daniel J. Donovan, Board Member and Chief Executive Officer
- Tom Dubin, Board Member
- Mark A. Goldberg, MD, Board Member
- Emer Leahy, Ph.D., Board Member
Last updated: 2024-12-31
Century Therapeutics, Inc.
CNTY-101
Century Therapeutics, Inc., a biotechnology company, develops transformative allogeneic cell therapies for the treatment of solid tumor and hematological malignancies.
Symbol: IPSC
Recent Price: $1.00
Industry: Biotechnology
CEO: Mr. Brent Pfeiffenberger M.B.A., Pharm.D.
Sector: Healthcare
Employees: 152
Address: 3675 Market Street, Philadelphia, PA 19104
Phone: 267 817 5790
Last updated: 2024-12-31
Intra-Cellular Therapies, Inc.
CAPLYTA
Intra-Cellular Therapies, Inc. is a biopharmaceutical company focused on developing novel drugs for the treatment of neuropsychiatric and neurologic diseases targeting intracellular signaling in the central nervous system. Key products include CAPLYTA for schizophrenia and ongoing developments in treatments for bipolar depression, autism spectrum disorder, and more.
About | About | Leadership | Directors | Sustainability | Contact | Careers | Careers | About | News | About | Careers
Symbol: ITCI
Recent Price: $83.48
Industry: Drug Manufacturers - Specialty & Generic
CEO: Dr. Sharon Mates Ph.D.
Sector: Healthcare
Employees: 610
Address: 430 East 29th Street, New York, NY 10016
Phone: 646 440 9333
Leadership
- Sharon Mates, Ph.D., Chairman, Founder & Chief Executive Officer
- Michael I. Halstead, J.D., President
- Mark Neumann, Executive Vice President, Chief Commercial Officer
- Suresh Durgam, M.D., Executive Vice President, Chief Medical Officer
- Sanjeev Narula, Executive Vice President, Chief Financial Officer
- John A. Bardi, Senior Vice President, Market Access, Policy and Government Affairs
- Robert E. Davis, Ph.D., Senior Vice President, Chief Scientific Officer
- Karen Sheehy, Esq., Senior Vice President and Chief Compliance Officer
- Michael Olchaskey, Pharm.D., Senior Vice President, Head of Regulatory Affairs
- Juan Sanchez, M.D., Vice President of Corporate Communications and Investor Relations
- Willie R. Earley, M.D., Senior Vice President, Head of Clinical Development
- Joel S. Marcus, J.D., CPA, Executive Chairman & Founder
- Rory B. Riggs, MBA, Co-Founder and Director
- E. Rene Salas, CPA, Former Senior Client Partner at Ernst & Young, LLP; Former CFO, Wellstat, LLC
- Robert L. Van Nostrand, Chairman, Metabolix; Board Member, Achillion Pharmaceuticals; Former CFO, OSI Pharmaceuticals
Last updated: 2024-12-31
Protagenic Therapeutics, Inc.
PT00114
Protagenic Therapeutics, Inc. is a biopharmaceutical company focused on discovering and developing therapeutics for stress-related neuropsychiatric and mood disorders. Its lead compound, PT00114, aims to regulate stress response and restore healthy brain function.
Symbol: PTIX
Recent Price: $0.54
Industry: Biotechnology
CEO: Dr. Garo H. Armen Ph.D.
Sector: Healthcare
Employees: 1
Address: 149 Fifth Avenue, New York, NY 10010
Phone: 212 994 8200
Last updated: 2024-12-31
Praxis Precision Medicines, Inc.
PRAX-114, PRAX-944, PRAX-562, PRAX-222, KCNT1 program
Praxis Precision Medicines, Inc. is a clinical-stage biopharmaceutical company focused on developing therapies for central nervous system disorders characterized by neuronal imbalance, with multiple products in different stages of clinical trials.
Symbol: PRAX
Recent Price: $76.26
Industry: Biotechnology
CEO: Mr. Marcio Silva De'Souza M.B.A.
Sector: Healthcare
Employees: 82
Address: 99 High Street, Boston, MA 02110
Phone: 617 300 8460
Last updated: 2024-12-31